Drug approval is actually a necessarily very long process, but for cannabis there are already the extra hurdles of legal roadblocks, together with the problem in getting patent protections for normal compounds.Synthetic cannabinoids (SCs) are a category of compounds related in pharmacological and physiological outcomes to tetrahydrocannabinol (THC)